Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Deltex Medical CEO discusses "traction" and "sales growth" in 2013

Ewan Phillips, CEO of Deltex Medical (LON:DEMG), discusses with Proactiveinvestors the outlook for 2013 and talks about both traction and sales growth being the key factors this year. Ewan also explains a bit about the recent news from the NHS, and what it means for Deltex, and also looks at the "excellent" potential for the company in the US.
 
Meet ReNeuron, ImmuPharma PLC, Abzena and VolitionRx at our event, London, 18 February 2016. Register here »
View full DEMG profile

Deltex Medical Group Timeline

Newswire
February 03 2016
Newswire
November 23 2015

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.